Phase II prospective randomized trial of weight loss prior to radical prostatectomy - Henning, Susanne M; Galet, Colette; Gollapudi, Kiran; Byrd, Joshua B.; Liang, Pei; Li, Zhaoping; Grogan, Tristan; Elashoff, David; Magyar, Clara E.; Said, Jonathan; Cohen, Pinchas; Aronson, William J. (Prostate cancer and prostatic diseases, 2018)
Keywords: 17β-Estradiol; 631/67/2195; 692/308/409; Adiponectin; Apoptosis; Biological markers; Biomarkers; Biomarkers - analysis; Biomedical and Life Sciences; Biomedicine; Biophysical methods; Body composition; Body fat; Body Mass Index; Body size; Body weight; Body weight loss; Caloric Restriction; Cancer; Cancer Research; Cancer surgery; Care and treatment; Case-Control Studies; Cell Proliferation; Cholesterol; Complications and side effects; Cytokines; Dietary restrictions; Epithelium; Estradiol; Estrogens; Exercise; Follow-Up Studies; Future predictions; Health aspects; Hip; Humans; Insulin; Insulin-like growth factors; Interleukin 6; Interleukin 8; Interleukins; Leptin; Male; Medical schools; Middle Aged; Mortality; Obesity; Obesity - physiopathology; Overweight; Overweight - physiopathology; Patients; Phenols (Class of compounds); Physical activity; Physical fitness; Prognosis; Prospective Studies; Prostate cancer; Prostatectomy; Prostatic Neoplasms - metabolism; Prostatic Neoplasms - pathology; Prostatic Neoplasms - surgery; Protein binding; Proteins; Risk factors; Sex hormones; Surgery; Testosterone; Triglycerides; Tumors; Urological surgery; Weight Loss